Gf Fund Management Co. Ltd. Collegium Pharmaceutical, Inc Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 826 shares of COLL stock, worth $22,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
826
Previous 677
22.01%
Holding current value
$22,302
Previous $19.4 Million
27.12%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
248Shares Held
37.2MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$156 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$71.2 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$63.5 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$61.6 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$57.8 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $921M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...